NBIX - Neurocrine Biosciences Inc.

$143.47 as of 2026-10-07 · Healthcare · Drug Manufacturers - Specialty & Generic · Stock

NBIX (Neurocrine Biosciences Inc.) is the #352 most-held security of 3,193 tracked on Upside Invest, held by 7 retail investors (1% of tracked portfolios), at an average allocation of 0.5% of their portfolio.

• Popularity rank: #352 of 3,193
• Holders on Upside: 7 retail investors
• Average allocation: 0.5%
• Average holder gain/loss: -0.8%
• Stock grade: C
• 30-day trading activity: 8 buys / 0 sells
• Market cap: $14.3B

Related Healthcare securities: LLY, UNH, JNJ, MRK, HIMS

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.